Ieq Capital LLC increased its position in shares of DaVita Inc. (NYSE:DVA – Free Report) by 60.2% in the third quarter, HoldingsChannel reports. The firm owned 56,880 shares of the company’s stock after acquiring an additional 21,370 shares during the quarter. Ieq Capital LLC’s holdings in DaVita were worth $9,949,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently bought and sold shares of DVA. Berkshire Hathaway Inc purchased a new position in DaVita during the 2nd quarter worth approximately $6,425,269,000. BlackRock Inc. acquired a new stake in DaVita during the 2nd quarter valued at approximately $547,520,000. Bank of America Corp DE purchased a new stake in shares of DaVita in the 2nd quarter valued at $145,057,000. Bank of New York Mellon Corp purchased a new stake in shares of DaVita in the 2nd quarter valued at $101,127,000. Finally, Deutsche Bank AG acquired a new stake in shares of DaVita in the second quarter worth $46,356,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.
DaVita Stock Up 3.0%
NYSE:DVA opened at $161.07 on Friday. DaVita Inc. has a 52 week low of $101.00 and a 52 week high of $247.49. The stock’s 50-day moving average price is $180.90 and its 200-day moving average price is $181.70. The stock has a market capitalization of $10.13 billion, a PE ratio of 11.86, a price-to-earnings-growth ratio of 0.41 and a beta of 0.87.
DaVita (NYSE:DVA – Get Free Report) last issued its quarterly earnings results on Thursday, October 29th. The company reported $3.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.57 by $0.25. The company had revenue of $3.58 billion for the quarter, compared to the consensus estimate of $3.52 billion. DaVita had a negative return on equity of 225.93% and a net margin of 6.49%. DaVita’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.51 earnings per share. Sell-side analysts expect that DaVita Inc. will post 14.66 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the company. TD Cowen increased their price target on DaVita from $220.00 to $228.00 and gave the stock a “buy” rating in a research report on Monday, November 2nd. Weiss Ratings raised DaVita from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, October 9th. UBS Group raised their target price on DaVita from $270.00 to $287.00 and gave the stock a “buy” rating in a report on Monday, November 2nd. Truist Financial reduced their price target on DaVita from $250.00 to $215.00 and set a “hold” rating for the company in a research report on Friday, August 7th. Finally, Wall Street Zen downgraded DaVita from a “buy” rating to a “hold” rating in a report on Saturday, October 31st. Four equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $235.86.
View Our Latest Stock Report on DVA
DaVita Profile
DaVita Inc. is a healthcare provider focused on kidney care. Its core business is operating outpatient dialysis centers that provide treatment and related services to people with chronic kidney failure. The company also offers home dialysis programs, provides dialysis services to patients in hospitals, and supports kidney care through services such as care coordination and education. DaVita primarily serves patients in the United States and also operates in international markets. Founded in 1994 as Total Renal Care, the company adopted the name DaVita in 2000.
Further Reading
- Five stocks we like better than DaVita
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.
